- Home
- FAAS vs CLDI Comparison
FAAS vs CLDI Comparison
Compare FAAS & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAAS
- CLDI
- Stock Information
- Founded
- FAAS 2021
- CLDI 2014
- Country
- FAAS Indonesia
- CLDI United States
- Employees
- FAAS N/A
- CLDI N/A
- Industry
- FAAS
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FAAS
- CLDI Health Care
- Exchange
- FAAS NYSE
- CLDI Nasdaq
- Market Cap
- FAAS 34.6M
- CLDI 35.2M
- IPO Year
- FAAS N/A
- CLDI N/A
- Fundamental
- Price
- FAAS $0.54
- CLDI $0.85
- Analyst Decision
- FAAS
- CLDI Strong Buy
- Analyst Count
- FAAS 0
- CLDI 3
- Target Price
- FAAS N/A
- CLDI $16.67
- AVG Volume (30 Days)
- FAAS 304.0K
- CLDI 1.2M
- Earning Date
- FAAS 09-17-2024
- CLDI 03-18-2025
- Dividend Yield
- FAAS N/A
- CLDI N/A
- EPS Growth
- FAAS N/A
- CLDI N/A
- EPS
- FAAS N/A
- CLDI N/A
- Revenue
- FAAS $57,730,593.00
- CLDI N/A
- Revenue This Year
- FAAS N/A
- CLDI N/A
- Revenue Next Year
- FAAS N/A
- CLDI N/A
- P/E Ratio
- FAAS N/A
- CLDI N/A
- Revenue Growth
- FAAS 38.16
- CLDI N/A
- 52 Week Low
- FAAS $0.38
- CLDI $0.58
- 52 Week High
- FAAS $12.97
- CLDI $8.30
- Technical
- Relative Strength Index (RSI)
- FAAS 46.84
- CLDI 42.34
- Support Level
- FAAS $0.50
- CLDI $0.70
- Resistance Level
- FAAS $0.57
- CLDI $0.95
- Average True Range (ATR)
- FAAS 0.08
- CLDI 0.14
- MACD
- FAAS 0.00
- CLDI -0.02
- Stochastic Oscillator
- FAAS 38.81
- CLDI 20.90
About FAAS DIGIASIA CORP
DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.